Who has invested in NeuroBo Pharmaceuticals?

Dong-A ST are named among the investors backing NeuroBo Pharmaceuticals.

NeuroBo Pharmaceuticals Funding: $32M Raised, Series A

NeuroBo Pharmaceuticals funding overview

NeuroBo Pharmaceuticals is based in New York. NeuroBo Pharmaceuticals has raised $32M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2022. The round record for NeuroBo Pharmaceuticals runs through 2022; nothing later has been disclosed. Investors on record include Dong-A ST.

NeuroBo Pharmaceuticals at a glance

Total raised: $32M
Latest round: Series A
Latest round date: September 2022
Headquarters: New York
Notable investors: Dong-A ST

Frequently asked about NeuroBo Pharmaceuticals funding

How much has NeuroBo Pharmaceuticals raised?: NeuroBo Pharmaceuticals has raised $32M in total disclosed funding across the rounds on record.
Who has invested in NeuroBo Pharmaceuticals?: Dong-A ST are named among the investors backing NeuroBo Pharmaceuticals.
What was the latest NeuroBo Pharmaceuticals funding round?: The most recent disclosed round is a Series A, announced in September 2022.
Where is NeuroBo Pharmaceuticals based?: NeuroBo Pharmaceuticals is based in New York.
When did NeuroBo Pharmaceuticals last raise?: The last disclosed NeuroBo Pharmaceuticals round closed in September 2022 at Series A.

Round data for NeuroBo Pharmaceuticals is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in New York and backer lists below.

NeuroBo Pharmaceuticals Funding: $32M Raised, Series A

NeuroBo Pharmaceuticals funding overview

NeuroBo Pharmaceuticals at a glance

Frequently asked about NeuroBo Pharmaceuticals funding

Companies related to NeuroBo Pharmaceuticals (18)

Browse related funding lists (5)